Professional Documents
Culture Documents
net/publication/362226105
CITATIONS READS
4 1,093
1 author:
Manish Shashi
Walden University
18 PUBLICATIONS 24 CITATIONS
SEE PROFILE
All content following this page was uploaded by Manish Shashi on 24 July 2022.
Abstract: Sustainability in the pharmaceutical integrated dispose of. Pharmaceutical industries are also heavily reliant
supply chain ecosystem is understood as a balance between on a large volume of water for formulation processes,
environmental, social, and economic pillars. Therefore, indicators production, and cleaning. Another aspect of social
for sustainability development in pharmaceutical industries sustainability in the pharmaceutical industry is developing
therefore must cover all three dimensions of sustainability. The
traditional supply chain was more about reducing costs and
and enhancing the community socially and economically.
maximizing revenue and profit. Now the corporate goal is also Increasing employment opportunities and providing balanced
about considering the environmental and social impact of their economic development for local communities is the main
products and services journey through the entire value chain — goal of social and economic pillars of sustainability [21].
from plan to source, to make, to deliver, to the service domain. Sustainable supply chain management encompasses both
Sustainability as part of corporate responsibilities is now social and economical goal while ensuring that the economic
mandatory to be mentioned as part of the broader commitment to
safeguarding the planet. This multiple qualitative case study
viability to achieve those goals generates a long-term
aimed to investigate the role of sustainability in the efficient advantage for the organization [4]. Implementing a
pharmaceutical supply chain. Sustainability is also the key driver sustainable initiative in the pharmaceutical supply chain is
for the long-term growth of a pharmaceutical company. The study quite similar to an operation initiative implemented after all
involved interviewing various pharmaceutical managers with the tradeoffs are evaluated. The lack of sustainability
proven strategies for implementing sustainability-related severely impacts a company’s profitability, and it is not only
strategies. The theory of constraint was used as the conceptual
framework for this qualitative multiple case study. Data from
the environment that is losing out. Unilever reported an
interviews and supporting documents were analyzed using data annual loss of €300m directly associated with climate change
triangulation to discover themes. Three main themes emerged [13]. The pharma industry’s contribution to environmental
from data analysis: (a) known or unknown constraints, (b) issues is expansive and linked to water and energy
business operational model change, and (c) training and building consumption, global distribution, large plant and warehouse
sustainability capability. Seven key strategies were developed footprints, R&D, the supply chain, and transport logistics
pertain to these three themes. These themes were identified based
on interview data inputs and documentation provided by
[12]. There is an ever-increasing consensus that
participants. Identified themes and strategies are summarized in environmental impacts (EIs) left uncontrolled, may result in
the system model. Researchers and industry leaders can utilize major changes to both the climate and the environmental
themes and strategies to identify constraints, risks, and issues in systems [21]. Governments are under immense pressure to
the current system and work towards a sustainable supply chain enact legislation to curb these impacts. These restrictions,
integrated ecosystem. which include controlling greenhouse gas emissions, more
Keywords: Sustainability, Pharmaceutical, Supply Chain,
Digitalization.
specifically carbon dioxide (CO2), are becoming a growing
interest and companies are being urged to incorporate these
I. INTRODUCTION issues into supply chain management schemes [21]. Among
these mechanisms and legislation, carbon emission trading or
Surprisingly confirmed that the pharmaceutical
the cap-and-trade system is generally accepted as one of the
most effective market-based mechanisms, which the EU and
industry is significantly more emission-intensive (55% UN have broadly accepted [21]. Pharmaceutical
higher) than the automotive industry [12]. As per organizations continue to lose millions because of spoilage
McKinsey’s research, the supply chain is the reason for 90% from temperature fluctuations and potential hazards for
of companies’ environmental impact. The toxic chemicals patients and subsequent regulatory actions [12]. With the
used in pharmaceutical production processes represent a right supply chain partner, a pharma company transporting 1
severe threat to the environment and sustainability. A billion vaccine doses could save 1 million MWh and 340
significant amount of waste is generated which is hard to million gallons of water, as well as reduce landfill
contributions by 3 million kg and CO2 emissions by 120
million kg [12]. Many firms are now making a pledge toward
Manuscript received on 20 July 2022.
Revised Manuscript received on 23 July 2022. sustainability and investing in that. Big pharmaceutical
Manuscript published on 30 August 2022. companies, such as Novartis, Genentech, and Johnson &
* Correspondence Author Johnson signed the American business activities pertaining to
Dr. Manish Shashi*, College of Management, Walden University, the climate pledge in the year 2015.
Minneapolis, MN, USA. Email: manish.shashi@gmail.com
Published By:
Retrieval Number: 100.1/ijeat.F37340811622 Blue Eyes Intelligence Engineering
DOI: 10.35940/ijeat.F3734.0811622 and Sciences Publication (BEIESP)
Journal Website: www.ijeat.org © Copyright: All rights reserved.
90
The Sustainability Strategies in the Pharmaceutical Supply Chain: A Qualitative Research
These companies are steadily demonstrating their environmental generations to meet their own needs [11]. As
sustainability commitment by reducing water usage, carbon defined by the triple bottom-down sustainability theory,
and greenhouse emissions, and waste in landfills. They are supply chain managers must consider social, economic, and
also showing commitment to using renewable energy. ecological objectives while deciding to make their business
profitable [17]. Sivarajah et al. (2020) further stated that
II. PROBLEM STATEMENT organizations must give back to the communities they
operate and must take initiatives to replenish and conserve
The most crucial challenge of the pharmaceutical supply
natural resources to provide services and manufacture
chain is to maintain sustainability by reducing carbon
tangible products [17]. Each sustainability type is discussed
footprints, water usage, waste and enhancing the
below in detail, starting with environmental sustainability.
socioeconomic aspects of local communities. The general
Globalization has prompted organizations to build highly
business problem is that some pharmaceutical managers lose
interconnected and complex supply chains. As a result,
supply chain efficiency, profitability, and business by not
companies adopt the outsourcing model to outsource
maintaining sustainability in their processes. The specific
non-core activities to overseas suppliers without much
business problem is that some pharmaceutical managers lack
consideration [16]. The shift toward outsourcing and waste
strategies to implement sustainability-related measures.
and emission caused by production processes throughout the
global supply chain is the primary source of environmental
III. RESEARCH QUESTION
issues [2]. In the current operating model, there has been an
The primary research question for this study was: What increase in third-party logistics and transportation (TPL)
strategies do pharmaceutical supply chain managers use to providers who were outsourced to serve the developing
improve sustainability to remain profitable? countries’ supply chain. The major challenges to
environmental sustainability in developing countries include
IV. RESEARCH METHOD a serious lack of collaboration between third-party logistics
This qualitative multiple case study aimed to explore the providers, a lack of governmental regulations for
strategies pharmaceutical managers use for improving environmental standards, a lack of environmental policy
sustainability metrics to remain profitable. My target initiatives and commitment by management, and a relatively
population included pharmaceutical supply chain managers immature stage of economic development in developing
who implemented these strategies to improve their systems. countries [6]. The need to coordinate activities between
The Purposive sample was used to select supply chain supply chain partners to satisfy environmental regulations
managers. imposed by governmental legislation and the requirement to
improve the company’s environmental profile for their
V. THEORETICAL FRAMEWORK potential customers are now deemed necessary for the
organizations [21]. The manufacturing processes may
The conceptual framework selected for this study was the consume energy and materials and, in the process, release
theory of constraints (TOC). Eliyahu Goldratt's (1990) TOC waste also in the ecosystem. Even the global supply chain’s
is a system-based management philosophy to understand and transportation process may adversely impact the environment
identify the root causes that limit a system from achieving regarding energy used and discard pharmaceutical raw
higher performance [7]. With TOC, digital supply chain material mismatch at source and destination. Nowadays, end
managers can formulate a robust design strategy in the early customers are demanding eco-friendly products and services
phase, continuously improving the digital processes by that do not damage the environment [9]. The demand from
identifying and analyzing constraints and solutions for every intermediate and end customers is now pushing
step of the digital supply chain system [16]. The TOC may manufacturers to rebuild or modify their operations. Ashby
help in providing the insights needed to determine why a (2018) suggested using the closed-loop supply chain by
non-digitalized cold chain system fails to achieve the taking example from the clothing industry, where the local
organization’s goals. A constraint is defined as an element of firm, customers, and global suppliers coordinate in a way that
the factor that limits the system from doing what it was follows appropriate environmental practices by initiating the
designed to accomplish [7]. Constraints hamper the progress reverse flow of used clothing toward maximizing the value
or increased throughput of an organization. Thus, the firm's and minimizing the waste in global supply chain lifecycle [2].
failure to manage this constraint leads to declines in its Implementing green SCM will improve environmental
productivity. The same TOC analogy can be made to the performance regarding fewer carbon footprints and help the
supply chain, where a non-sustainable supply chain system competitive advantages and economic performance of an
can limit the entire supply chain's effectiveness and organization [1]. Social sustainability in the supply chain also
efficiency [16]. plays a substantial role, as supply chain managers and
partners must address stakeholders’ needs and human capital
VI. LITERATURE REVIEW to achieve long-term sustainable results.
Sustainability is protecting stakeholders’ interests by
focusing on non-financial environments, such as
environmental, social, ethical, and governance, by
accomplishing financial performance and creating
stockholders’ s value [20]. Sustainability is described as
meeting the present’s needs without compromising
Published By:
Retrieval Number: 100.1/ijeat.F37340811622 Blue Eyes Intelligence Engineering
DOI: 10.35940/ijeat.F3734.0811622 and Sciences Publication (BEIESP)
Journal Website: www.ijeat.org © Copyright: All rights reserved.
91
International Journal of Engineering and Advanced Technology (IJEAT)
ISSN: 2249-8958 (Online), Volume-11 Issue-6, August 2022
Socially sustainable supply chain practices are defined as sustainability impacts. Several organizations, such as TSC,
introducing a range of initiatives, including protection the world wildlife fund (WWF), the sustainability accounting
against child and slave labor, health and safety programs for standard boards, CDP, and the global reporting initiatives,
employees, outreach to communities, and supporting human offer measurement frameworks and instruments that can help
rights [5]. Organizations have adopted social and companies find the most critical sustainability issues across
environmental sustainability practices to reduce their carbon their supply chain [3]. LEED (leadership in energy and
footprints and improve their image on the social front [8]. environmental design) certification helps pharmaceutical
Organizations that adopt sustainable practices in their supply organizations provide a framework for highly efficient,
chain processes outperform their competitors in stock market cost-saving green buildings [15]. The certification
performance and financial metrics [18]. independently validates that building design, construction,
operations, and maintenance are energy and
VII. FINDING OF THE RESEARCH resource-efficient [15]
I have used ATLAS.ti, and codings are done to identify Theme 2: Business operational model change
appropriate themes. ATLAS.ti is a qualitative research tool The second theme that emerged during the interviews was the
that can be used for coding and developing themes using need for a modified business model to work through the
interview transcripts, documentation, and field notes. It also sustainability issue mapped in each stage of the current
provides in-depth insights into data visualization. I have used supply chain. The sustainability team in a pharmaceutical
the word cloud feature in ATLAS.ti to show the visual organization can be internal, belonging to the company, or
representation of all the words during interviews with the external, belonging to some NGOs. These teams can be
participants. During data analysis, three main themes tasked with a specific task in sustainability that pertains to
emerged: (a) known or unknown constraints, (b) business particular problem areas such as logistics (efficient transport,
operational model change, and (c) training and building repackaging, fuels), sourcing, and environmentally
capacity. Seven key strategies were developed pertaining to responsible procurement activities. They are also assigned to
these three themes. These are discussed in detail: evaluate financial benefits based on all sustainability-related
Theme 1: Known or unknown constraints measures. External agencies may help to create and
communicate a uniform code of sustainable action
The first theme that emerged during the interviews was the
industry-wide. Digitalization also plays a significant role in
identification of constraints in the current supply chain
improving sustainability indicators. The following three
system. All participants emphasized the need to work through
key strategies emerged pertain to the second theme:
first and identify the known issue or constraints in their
supply chain system. Participants’ interview data and 1. Innovating packaging design and materials
documentation suggested that an analysis of the current The pharmaceutical companies do have stringent regulations
system must be done before deciding on the next step. regarding the safety of the packaging. Packaging must be
Identification of all known or unknown constraints must be temper resistant and, unlike other industries, meant for single
part of the supply chain system analysis. The following two use. Reusing or refilling is not possible in pharmaceutical
key strategies emerged pertain to the first theme: industries. Pharmaceutical companies must work towards
1. Work through identified constraints innovating packaging material instead of just using
single-use conventional blister packaging. Recent innovation
The major constraints that leaders of a pharmaceutical
happened in the form of the development of polyolefin
company face include (a) over-dependency on third-party
laminate as an alternative packaging material that is 70%
manufacturers (contract manufacturing), (b) cold chain
recyclable and may lower the packaging-associated cost by
process for transporting biopharma products, (c) Special
60% [15]. There is also innovation around using bioplastic
packaging requirements. The other constraints include (a)
derived from renewable plant-based biodegradable sources
over-relying on single sourcing vendors for raw materials
and bio base effervescent tablet packaging derived from corn
(active pharmaceutical ingredients and active biological
and sugarcane [15].
ingredients) and not improving continuity of supply by
shifting to multiple suppliers in a different part of the world, 2. Digitalization by implementing digital enablers:
(b) non digitalized system. Based on all the constraints, Organizations have already acknowledged the significant
pharmaceutical companies need to develop their vision to impacts of innovative digital technologies, as enablers of
implement various measures related to sustainability. sustainable initiatives and for improving supply chain
Developing vision provides direction and clearly describes performances (Fuchs, 2008). Digital enablers, such as
the big picture in the short and long term. Developing a vision blockchain can help track and trace whether products are
is also one of the critical metrics for cultural change to bring environmentally produced and shipped (Anna, 2020).
digital transformations. Blockchain traceability can also help determine social
2. Locate and map critical sustainability issues across the sustainability aspects if fair and safe work practices are
supply chain followed and human rights were not violated in producing the
To understand the impact, organizations must analyze how products and services.
natural or human resources are used at each stage of the
supply chain, such as production, sourcing, and
transportation. Organizations must map supply chain
processes with a comprehensive understanding of the
Published By:
Retrieval Number: 100.1/ijeat.F37340811622 Blue Eyes Intelligence Engineering
DOI: 10.35940/ijeat.F3734.0811622 and Sciences Publication (BEIESP)
Journal Website: www.ijeat.org © Copyright: All rights reserved.
92
The Sustainability Strategies in the Pharmaceutical Supply Chain: A Qualitative Research
Pharmaceutical organizations must digitize supply chain 1. Establish the sustainability center of excellence (COE):
indicators instead of just keep them in manual format and COE can help in improving sustainability and behavioral
then apply digital enablers to harness the benefits. Digital changing of all partners of the supply chain ecosystem
tools like augmented reality are used for better workforce towards sustainability. COE can establish best practice
engagement and machine learning for identifying resources industrywide and not limited to their own domain
sustainability risks. As per Gartner, digital enablers enhance only. Regular training by COE must be conducted not only
visibility, digitalization, and collaborations required for for their employees but also for suppliers and external
progressing evaluation of sustainability programs in partners. COE may collaborate with external organizations
pharmaceutical organizations. Digital analytical capabilities, and must attend sustainability summits to bring different
including machine learning (ML) and predictive analytics of perspectives. It will help pharmaceutical organizations to
a pharmaceutical organization, can help transform data into optimize sustainability for the entire supply chain ecosystem.
insights. An intelligent and informed decision can be taken to
2. Establish a baseline, develop KPIs and track progress:
monitor sustainability-related metrics. Digitalization may
provide opportunities for pharmaceutical organizations to Establishing baseline metrics helps organizations access
work with stakeholders and build trust by sharing the improvement need and serves as a starting point.
information pertaining to broader sustainability strategies. Collecting data from suppliers through self-assessment about
compliance standards may provide a starting point for the
3. Improve continuity of supply by establishing a supplier vendor’s sustainability capability. Their performances must
code of conduct:
match the supplier code of conduct as discussed in the
Depending on and over-relying on a single source of previous strategy. Pharmaceutical industries have already
supply can result in shortages, delays, and reputation developed industrywide surveys to reduce the burden on
damages if the vendor is not following sustainable norms as suppliers of responding to multiple requests for information
defined for one of the critical vendor selection criteria. which varies in format and content by each company [19].
Pharmaceutical companies must diversify their supplier list The suppliers and other external partners also need to be
in different geographies. Organizations must develop a provided regular feedback regarding their help in the
strategic partnership with external vendors with a vision and organization’s sustainability effort. They need to be engaged
proven expertise toward a sustainable business. A supplier constructively, and any additional action must be
code of conduct is a prominent and critical step to encouraged. Retaining existing suppliers or providing more
communicating and establishing expectations in the business to suppliers with strong sustainability performances
pharmaceutical company’s sustainability effort. can help drive continuous improvement and increase
Theme 3: Training and building capacity. efficiencies in the supply chain. A digitalized sustainability
The third theme that emerged during the interviews was a dashboard can ensure all critical sustainability metrics and
need for developing capabilities for sustainability-related the actionable items for the organizations. The dashboard
pieces of training. They also discussed establishing a may provide visibility to all the stakeholders in the
dedicated department to work with all stakeholders. The organization.
following two key strategies emerged pertain to the third
theme:
Published By:
Retrieval Number: 100.1/ijeat.F37340811622 Blue Eyes Intelligence Engineering
DOI: 10.35940/ijeat.F3734.0811622 and Sciences Publication (BEIESP)
Journal Website: www.ijeat.org © Copyright: All rights reserved.
94
The Sustainability Strategies in the Pharmaceutical Supply Chain: A Qualitative Research
AUTHOR PROFILE
Dr. Manish Shashi, is a global supply chain senior
leader and a researcher. Dr. Shashi has more than
28 years of experience working globally in more
than 12 countries, including APAC, Europe,
EAMER, and the Americas geographies. Dr.
Shashi earned a mechanical engineering degree
from NIT, Surat, MBA from DBIM, India, a Lean
Six Sigma Black lack belt from Villanova
University, PA, USA, a master’s in management from Saint Elizabeth, NJ,
USA, and a doctorate from Walden University, MN, USA. Dr. Shashi is also
associated with MIT, the USA, pertains to the digital transformation
program.
Published By:
Retrieval Number: 100.1/ijeat.F37340811622 Blue Eyes Intelligence Engineering
DOI: 10.35940/ijeat.F3734.0811622 and Sciences Publication (BEIESP)
Journal Website: www.ijeat.org © Copyright: All rights reserved.
View publication stats
95